Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 12006291 Processes for the preparation of 4,6,7-trifluoro-1H-indole-2-carboxylic acid

Patent 12006291 was granted and assigned to Enanta Pharmaceuticals on June, 2024 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Enanta Pharmaceuticals

Current Assignee

Enanta Pharmaceuticals

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

120062910

Patent Inventor Names

Kaicheng Zhu0

Yat Sun Or0

Jiajun Zhang0

Hui Cao0

Guoqiang Wang0

Tao Wang0

George G. Wu0

Ruichao Shen0

Date of Patent

June 11, 2024

Patent Application Number

180951550

Date Filed

January 10, 2023

Patent Citations

‌

US Patent 11358953 Functionalized peptides as antiviral agents

‌

US Patent 11319325 Macrocyclic spiropyrrolidine derived antiviral agents

‌

US Patent 11325916 Spiropyrrolidine derived antiviral agents

‌

US Patent 11339170 Spiropyrrolidine derived antiviral agents

‌

US Patent 11352363 Spiropyrrolidine derived antiviral agents

‌

US Patent 11384090 Spiropyrrolidine derived antiviral agents

Patent Primary Examiner

CPC Code

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 12006291 Processes for the preparation of 4,6,7-trifluoro-1H-indole-2-carboxylic acid

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API